Results 51 to 60 of about 14,789 (299)

Updating predictors of endoscopic recurrence after ileocolic resection for Crohn disease [PDF]

, 2017
Background/Aims: Identifying predictors of endoscopic recurrence (ER) has become very important to guide the decision of postoperative strategy. This study aimed to determine the rate of endoscopic recurrence until 12 months after ileocolic resection for
Carvalho, Pedro Boal, Cotter, José Almeida Berkeley, Gonçalves, Tiago Cúrdia, Monteiro, Sara, Moreira, Maria João   +4 more
core   +1 more source

Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications

Canadian Journal of Gastroenterology and Hepatology, 2016
Background. Ulcerative proctitis (UP) is typically treated initially with oral 5-aminosalicylate (“5-ASA”), mesalamine suppository, or mesalamine enema (“UP Rx”). Little is known about their effectiveness in practice. Methods. Using a US health insurance
James M. Richter, Nabeela K. Arshi, Gerry Oster   +2 more
doaj   +1 more source

Medications as a Source of Human Exposure to Phthalates. [PDF]

, 2012
Phthalates are a group of multifunctional chemicals used in consumer and personal care products, plastics, and medical devices. Laboratory studies show that some phthalates are reproductive and developmental toxicants.
Calafat, Antonia M, Duty, Susan M., Godfrey-Bailey, Linda, Hauser, Russ B.   +3 more
core   +1 more source

pH-Sensitive Hydrogels Fabricated with Hyaluronic Acid as a Polymer for Site-Specific Delivery of Mesalamine

ACS Omega
Hydrogels with the main objective of releasing mesalamine (5-aminosalicylic acid) in the colon in a modified manner were formulated in the present work using a free-radical polymerization approach.
Huma Liaqat, Syed Faisal Badshah, M. Minhas, Kashif Barkat, S. A. Khan, Muhammad Delwar Hussain, Mohsin Kazi   +6 more
semanticscholar   +1 more source

Development and Optimization of RP-UHPLC Method for Mesalamine Through QbD Approach

Dhaka University Journal of Pharmaceutical Sciences, 2022
The current study aimed at developing and optimizing a prompt, simple and efficient RP-UHPLC method based on Quality by Design (QbD) for analyzing mesalamine.
Diponkor Kumar Shill, U. Kumar, Asm Monjur Al Hossain, Md. Rezowanur Rahman, Abu Shara Shamsur Rouf   +4 more
semanticscholar   +1 more source

Retrospective investigation of mesalamine intolerance in patients with ulcerative colitis

Journal of clinical biochemistry and nutrition, 2022
Mesalamine is a key drug in the treatment of ulcerative colitis (UC) for both induction and maintenance therapy. On the other hand, it is known that there are some cases of mesalamine intolerance that are difficult to distinguish from symptoms due to ...
Y. Minagawa, K. Uchiyama, T. Takagi, K. Mizushima, Kohei Asaeda, Mariko Kajiwara-Kubota, Saori Kashiwagi, Yuma Hotta, Makoto Tanaka, Ken Inoue, O. Dohi, Tetsuya Okayama, Naohisa Yoshida, K. Katada, Kazuhiro Kamada, T. Ishikawa, H. Yasuda, H. Konishi, Y. Naito, Y. Itoh   +19 more
semanticscholar   +1 more source

Ulcerative proctitis: an update on the pharmacotherapy and management. [PDF]

, 2014
Introduction: Ulcerative colitis (UC) presents as proctitis in approximately a quarter of the patients. It may progress into left-sided or extensive colitis in up to 50% of cases upon long-term follow-up.Areas covered: Currently available data on ...
Gecse, Krisztina, Lakatos, Péter László   +1 more
core   +1 more source

Efficacy and Safety of Bifidobacterium Quadruple Viable Bacteria Combined with Mesalamine against UC Management: A Systematic Review and Meta-Analysis

Oxidative Medicine and Cellular Longevity, 2022
Objective. To systematically assess effectiveness and safety of Bifidobacterium quadruple viable bacteria combined with mesalamine against ulcerative colitis (UC) in the Asian population. Methods.
Fei Xie, Shichao Li, Yao Fan, Wusheng Li, Qijun Lv, Xin Sun, Yingshuang Chen, Xiangdong Yang   +7 more
semanticscholar   +1 more source

The decline of 6‐thioguanine nucleotides is not linked to impaired efficacy or safety of thiopurines in pregnant women with inflammatory bowel disease

British Journal of Clinical Pharmacology, EarlyView.
Background Thiopurines are used to maintain remission in inflammatory bowel disease (IBD). These drugs are metabolized into 6‐thioguanine nucleotides (6‐TGN), associated with efficacy, and 6‐methylmercaptopurine ribonucleotides (6‐MMPR), associated with adverse drug reactions. Pregnancy has been linked to a shift in thiopurine metabolism, characterized
Dianne G. Bouwknegt, Paola Mian, Femke Groen, Denise van den Berg‐Zuiddam, Andrea E. van der Meulen, Femke Crouwel, Nanne K. de Boer, Debbie S. Deben, Dennis R. Wong, Luc J. J. Derijks, Gerard Dijkstra, Arno R. Bourgonje, C. Janneke van der Woude, Marijn C. Visschedijk   +13 more
wiley   +1 more source

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection [PDF]

, 2018
L
Altorjay, István, Blank, Marion, Chevrier, Marc, Cornillie, Freddy J., Danese, Silvio, Feagan, Brian, Gionchetti, Paolo, Hanauer, Stephen B., Johanns, Jewel, Lukas, Milan, Plevy, Scott, Popp, John, Regueiro, Miguel, Reinisch, Walter, Rutgeerts, Paul, Sandborn, William J., Sorrentino, Dario, Zou, Bin   +17 more
core   +1 more source